Table 2.
Results of the seropositive human participants to Coxiella burnetii phase I and phase II antigens
No | Group | Farm number | Phase I | Phase II |
---|---|---|---|---|
1 | S | 1 | Negative | 1/32 |
2 | S | 2 | 1/32 | Negative |
3 | S | 3 | 1/128 | Negative |
4 | S | 4 | 1/32 | Negative |
5 | S | 4 | 1/32 | Negative |
6 | S | 5 | Negative | 1/32 |
7 | S | 6 | 1/32 | 1/64 |
8 | S | 7 | 1/64 | Negative |
9 | S | 8 | 1/128 | 1/256 |
10 | S | 8 | 1/32 | Negative |
11 | S | 9 | 1/32 | Negative |
12 | S | 10 | 1/128 | 1/32 |
13 | S | 11 | 1/128 | 1/256 |
14 | S | 12 | 1/32 | 1/32 |
15 | S | 13 | 1/32 | Negative |
16 | S | 14 | 1/32 | 1/32 |
17 | S | 14 | 1/32 | Negative |
18 | S | 15 | 1/64 | Negative |
19 | S | 16 | 1/64 | 1/32 |
20 | S | 17 | 1/32 | Negative |
21 | S | 18 | Negative | 1/32 |
22 | S | 19 | 1/64 | 1/64 |
23 | S | 20 | 1/32 | 1/128 |
24 | C | Not applicable | Negative | 1/64 |
C Control group; S Shepherd group